DMale fertility and sperm quality
Not recommended
Male fertility and sperm quality
Not recommended
D-aspartic acid is marketed to improve semen analysis on the strength of D'Aniello 2012, where sperm concentration and motility roughly doubled over 90 days in 60 subfertile men. That study was open-label, had no placebo and no randomization, and appeared in a journal not indexed in PubMed, so it cannot establish the effect. A 2017 systematic review by Roshanzamir and Safavi found only four human trials and rated the evidence sparse and inconsistent, while a placebo-controlled trial in trained men (Melville 2017) showed no rise in testosterone. The one positive randomized placebo-controlled trial (GamalEl Din 2025) combined D-aspartic acid with ubiquinol and zinc, so its benefit cannot be attributed to the amino acid alone. No serious adverse effects are documented at roughly 2.66 g per day, but a fertility benefit remains unproven.
Sources
- Archivio Italiano di Urologia e Andrologia: Evaluation of in vivo supplementation of 2660 mg D-aspartic acid and 200 mg ubiquinol and 10 mg zinc on different semen parameters in idiopathic male infertility: a randomized double blind placebo controlled study (2025)
- Advances in Sexual Medicine: D-Aspartate, a Key Element for the Improvement of Sperm Quality (2012)
- International Journal of Reproductive BioMedicine: The putative effects of D-Aspartic acid on blood testosterone levels: A systematic review (2017)
ICD-10: N46.9 · ICD-11: GB04